Literature DB >> 21710792

Amplification of neuromuscular transmission by postjunctional folds.

A R Martin1.   

Abstract

Previously, suggestions have been made that postjunctional folds at the vertebrate motor end plate might, in some way, serve to enhance neuromuscular transmission. This suggestion was examined quantitatively using a model junction with geometry similar to that seen in mammalian 'fast twitch' muscles. It was found that the depolarization produced at the top of an interfold by a quantum of acetylcholine is significantly greater than that produced in the absence of folds because of the series resistance of the interfold myoplasm. As a result, voltage-sensitive sodium channels in the postsynaptic membrane are activated more readily. In the model, activation of as few as four interfolds by eight quanta is sufficient for excitation to spread to the remainder of the muscle. With no folds, 19 quanta are required.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 21710792     DOI: 10.1098/rspb.1994.0180

Source DB:  PubMed          Journal:  Proc Biol Sci        ISSN: 0962-8452            Impact factor:   5.349


  16 in total

1.  Sodium channel mRNAs at the neuromuscular junction: distinct patterns of accumulation and effects of muscle activity.

Authors:  S S Awad; R N Lightowlers; C Young; Z M Chrzanowska-Lightowlers; T Lomo; C R Slater
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

2.  Structure/function assessment of synapses at motor nerve terminals.

Authors:  A F M Johnstone; K Viele; R L Cooper
Journal:  Synapse       Date:  2010-09-17       Impact factor: 2.562

3.  Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome.

Authors:  Grace M McMacken; Sally Spendiff; Roger G Whittaker; Emily O'Connor; Rachel M Howarth; Veronika Boczonadi; Rita Horvath; Clarke R Slater; Hanns Lochmüller
Journal:  Hum Mol Genet       Date:  2019-07-15       Impact factor: 6.150

Review 4.  Invaginating Presynaptic Terminals in Neuromuscular Junctions, Photoreceptor Terminals, and Other Synapses of Animals.

Authors:  Ronald S Petralia; Ya-Xian Wang; Mark P Mattson; Pamela J Yao
Journal:  Neuromolecular Med       Date:  2017-06-13       Impact factor: 3.843

5.  Endplate structure and parameters of neuromuscular transmission in sporadic centronuclear myopathy associated with myasthenia.

Authors:  Teerin Liewluck; Xin-Ming Shen; Margherita Milone; Andrew G Engel
Journal:  Neuromuscul Disord       Date:  2011-04-08       Impact factor: 4.296

6.  Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome.

Authors:  Kinji Ohno; Andrew G Engel; Xin-Ming Shen; Duygu Selcen; Joan Brengman; C Michel Harper; Akira Tsujino; Margherita Milone
Journal:  Am J Hum Genet       Date:  2002-01-14       Impact factor: 11.025

7.  Myasthenic syndrome caused by plectinopathy.

Authors:  D Selcen; V C Juel; L D Hobson-Webb; E C Smith; D E Stickler; A V Bite; K Ohno; A G Engel
Journal:  Neurology       Date:  2011-01-25       Impact factor: 9.910

Review 8.  The therapy of congenital myasthenic syndromes.

Authors:  Andrew G Engel
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

9.  Myasthenic syndrome caused by mutation of the SCN4A sodium channel.

Authors:  Akira Tsujino; Chantal Maertens; Kinji Ohno; Xin-Ming Shen; Taku Fukuda; C Michael Harper; Stephen C Cannon; Andrew G Engel
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-23       Impact factor: 11.205

10.  How myasthenia gravis alters the safety factor for neuromuscular transmission.

Authors:  Robert L Ruff; Vanda A Lennon
Journal:  J Neuroimmunol       Date:  2008-07-15       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.